About Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen
Clinical Trials at Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen
During the past decade, Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen"
#1 collaborator was "ClinStat GmbH" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Institut Dr. Schauerte (IDS)" with 1 trials as a collaborator, "Institut Dr. Schauerte GmbH (IDS)" with 1 trials as a collaborator and "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen
According to Clinical.Site data, the most researched conditions in "Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen" are
"End Stage Renal Disease" (2 trials), "Renal Failure" (2 trials), "Chronic Kidney Disease" (1 trials), "Chronic Kidney Disease (CKD)" (1 trials) and "ESRD" (1 trials). Many other conditions were trialed in "Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen" in a lesser frequency.
Clinical Trials Intervention Types at Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen
Most popular intervention types in "Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Dialyser" (2 trials), "Empagliflozin" (1 trials) and "Matching placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen
The vast majority of trials in "Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen" are
5 trials for "All" genders.
Clinical Trials Status at Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen
Currently, there are NaN active trials in "Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".